| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.809 | 0.005 | 0.809 | Angiogenesis inhibitor | |||
| 0.727 | 0.001 | 0.727 | Thymidine phosphorylase inhibitor | 0.168 0.002 DBMET01853 | ||
| 0.659 | 0.003 | 0.659 | NMDA 2B receptor antagonist | |||
| 0.276 | 0.038 | 0.465 | RNA-directed DNA polymerase inhibitor | 0.465 0.013 DBMET01853 | DBMET01853 | |
| 0.186 | 0.014 | 0.186 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.329 | 0.176 | 0.373 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.373 0.126 DBMET01853 | DBMET01853 | |
| 0.223 | 0.073 | 0.326 | Peptidyltransferase inhibitor | 0.326 0.017 DBMET01853 | DBMET01853 | |
| 0.153 | 0.004 | 0.153 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.154 | 0.023 | 0.229 | DNA directed RNA polymerase inhibitor | 0.229 0.01 DBMET01853 | DBMET01853 | |
| 0.147 | 0.034 | 0.147 | Nav1.1 sodium channel blocker | 0.101 0.065 DBMET01853 | ||
| 0.149 | 0.055 | 0.149 | Nav1.6 sodium channel blocker | |||
| 0.269 | 0.18 | 0.306 | DNA directed DNA polymerase inhibitor | 0.306 0.158 DBMET01853 | DBMET01853 | |
| 0.112 | 0.022 | 0.112 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.134 | 0.062 | 0.134 | Glutamate receptor antagonist | |||
| 0.101 | 0.031 | 0.101 | NMDA 2 receptor antagonist | |||
| 0.075 | 0.009 | 0.098 | Thymidine kinase inhibitor | 0.098 0.006 DBMET01853 | DBMET01853 | |
| 0.111 | 0.063 | 0.111 | 5 Hydroxytryptamine 3A agonist | |||
| 0.082 | 0.041 | 0.285 | HIV-1 reverse transcriptase inhibitor | 0.285 0.005 DBMET01853 | DBMET01853 | |
| 0.078 | 0.039 | 0.078 | Secretase beta inhibitor | |||
| 0.099 | 0.077 | 0.099 | Nav1.4 sodium channel blocker | |||
| 0.107 | 0.089 | 0.107 | Nav1.3 sodium channel blocker | |||
| 0.222 | 0.209 | 0.222 | DNA polymerase beta inhibitor | |||
| 0.024 | 0.012 | 0.024 | Alpha 2d adrenoreceptor agonist | |||
| 0.106 | 0.102 | 0.106 | Nav1.2 sodium channel blocker | |||
| 0.031 | 0.029 | 0.072 | Protein kinase (CK2) beta inhibitor | 0.072 0.004 DBMET01853 | DBMET01853 | |
| 0.092 | 0.09 | 0.104 | Factor V inhibitor | 0.104 0.061 DBMET01853 | DBMET01853 | |
| 0.004 | 0.021 | 0.015 | DNA topoisomerase III inhibitor | 0.015 0.003 DBMET01853 | DBMET01853 | |
| 0.032 | 0.057 | 0.08 | Thymidylate synthase inhibitor | 0.08 0.007 DBMET01853 | DBMET01853 | |
| 0.141 | 0.169 | 0.551 | Cyclic AMP phosphodiesterase inhibitor | 0.551 0.005 DBMET01853 | DBMET01853 | |
| 0.057 | 0.086 | 0.083 | Phospholipase D inhibitor | 0.083 0.03 DBMET01853 | DBMET01853 | |
| 0.022 | 0.051 | 0.036 | DNA polymerase III inhibitor | 0.036 0.007 DBMET01853 | DBMET01853 | |
| 0.01 | 0.04 | 0.021 | Thyroid hormone alpha agonist | 0.021 0.006 DBMET01853 | DBMET01853 | |
| 0.01 | 0.042 | 0.016 | DNA polymerase III polC-type inhibitor | 0.016 0.005 DBMET01853 | DBMET01853 | |
| 0.139 | 0.173 | 0.344 | Vasodilator | 0.344 0.035 DBMET01853 | DBMET01853 | |
| 0.015 | 0.049 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.029 0.005 DBMET01853 | DBMET01853 | |
| 0.069 | 0.105 | 0.289 | NADH dehydrogenase inhibitor | 0.289 0.007 DBMET01853 | DBMET01853 | |
| 0.057 | 0.095 | 0.082 | MDM2 inhibitor | 0.082 0.018 DBMET01853 | DBMET01853 | |
| 0.02 | 0.06 | 0.039 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.039 0.005 DBMET01853 | DBMET01853 | |
| 0.006 | 0.047 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 DBMET01853 | DBMET01853 | |
| 0.012 | 0.059 | 0.13 | Uridine phosphorylase inhibitor | 0.13 0.002 DBMET01853 | DBMET01853 | |
| 0.096 | 0.146 | 0.233 | Cell wall synthesis inhibitor | 0.233 0.019 DBMET01853 | DBMET01853 | |
| 0.04 | 0.092 | 0.149 | Dihydroorotate oxidase inhibitor | 0.149 0.003 DBMET01853 | DBMET01853 | |
| 0.016 | 0.074 | 0.028 | Acid ceramidase inhibitor | 0.028 0.012 DBMET01853 | DBMET01853 | |
| 0.021 | 0.079 | 0.049 | Purinergic P2Y2 antagonist | 0.049 0.011 DBMET01853 | DBMET01853 | |
| 0.1 | 0.162 | 0.196 | Growth hormone agonist | 0.196 0.06 DBMET01853 | DBMET01853 | |
| 0.116 | 0.18 | 0.506 | Aldehyde oxidase inhibitor | 0.506 0.032 DBMET01853 | DBMET01853 | |
| 0.007 | 0.082 | 0.061 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.061 0.007 DBMET01853 | DBMET01853 | |
| 0.06 | 0.14 | 0.445 | UDP-glucose 4-epimerase inhibitor | 0.445 0.004 DBMET01853 | DBMET01853 | |
| 0.005 | 0.093 | 0.011 | Purine nucleoside phosphorylase inhibitor | 0.011 0.01 DBMET01853 | DBMET01853 | |
| 0.019 | 0.108 | 0.093 | Antimetabolite | 0.093 0.017 DBMET01853 | DBMET01853 | |
| 0.089 | 0.181 | 0.151 | Psychostimulant | 0.151 0.116 DBMET01853 | DBMET01853 | |
| 0.026 | 0.119 | 0.063 | Kainate receptor agonist | 0.063 0.006 DBMET01853 | DBMET01853 | |
| 0.028 | 0.121 | 0.139 | Carbamoyl phosphate synthetase inhibitor | 0.139 0.013 DBMET01853 | DBMET01853 | |
| 0.029 | 0.135 | 0.273 | Phosphodiesterase III inhibitor | 0.273 0.005 DBMET01853 | DBMET01853 | |
| 0.054 | 0.162 | 0.176 | M18 aspartyl aminopeptidase inhibitor | 0.176 0.041 DBMET01853 | DBMET01853 | |
| 0.101 | 0.217 | 0.324 | Immunostimulant | 0.324 0.072 DBMET01853 | DBMET01853 | |
| 0.143 | 0.262 | 0.272 | Antithrombotic | 0.272 0.11 DBMET01853 | DBMET01853 | |
| 0.01 | 0.131 | 0.051 | Nicotinic acid receptor 2 antagonist | 0.051 0.004 DBMET01853 | DBMET01853 | |
| 0.087 | 0.211 | 0.178 | DNA methyltransferase I inhibitor | 0.178 0.081 DBMET01853 | DBMET01853 | |
| 0.052 | 0.177 | 0.374 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.374 0.004 DBMET01853 | DBMET01853 | |
| 0.101 | 0.23 | 0.246 | Spasmolytic | 0.246 0.093 DBMET01853 | DBMET01853 | |
| 0.019 | 0.152 | 0.2 | Nicotinic acid receptor 1 agonist | 0.2 0.004 DBMET01853 | DBMET01853 | |
| 0.126 | 0.26 | 0.387 | DNA synthesis inhibitor | 0.387 0.023 DBMET01853 | DBMET01853 | |
| 0.023 | 0.157 | 0.214 | Biliverdin reductase inhibitor | 0.214 0.005 DBMET01853 | DBMET01853 | |
| 0.02 | 0.155 | 0.178 | Argininosuccinate synthase inhibitor | 0.178 0.009 DBMET01853 | DBMET01853 | |
| 0.149 | 0.29 | 0.334 | GABA C receptor rho-3 antagonist | 0.334 0.094 DBMET01853 | DBMET01853 | |
| 0.048 | 0.191 | 0.233 | GABA C receptor agonist | 0.233 0.015 DBMET01853 | DBMET01853 | |
| 0.011 | 0.155 | 0.048 | Thyroid hormone agonist | 0.048 0.005 DBMET01853 | DBMET01853 | |
| 0.045 | 0.19 | 0.146 | HIV-1 integrase (Overall Integration) inhibitor | 0.146 0.027 DBMET01853 | DBMET01853 | |
| 0.084 | 0.236 | 0.181 | DNA methylase inhibitor | 0.181 0.092 DBMET01853 | DBMET01853 | |
| 0.024 | 0.177 | 0.072 | Phosphodiesterase 7A inhibitor | 0.072 0.01 DBMET01853 | DBMET01853 | |
| 0.009 | 0.165 | 0.077 | Fumarate hydratase inhibitor | 0.077 0.007 DBMET01853 | DBMET01853 | |
| 0.022 | 0.18 | 0.235 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.235 0.006 DBMET01853 | DBMET01853 | |
| 0.03 | 0.187 | 0.07 | Cathepsin G inhibitor | 0.07 0.054 DBMET01853 | DBMET01853 | |
| 0.011 | 0.176 | 0.029 | Integrin alpha2beta1 antagonist | 0.029 0.014 DBMET01853 | DBMET01853 | |
| 0.044 | 0.213 | 0.293 | Ferrochelatase inhibitor | 0.293 0.008 DBMET01853 | DBMET01853 | |
| 0.011 | 0.185 | 0.094 | Ornithine carbamoyltransferase inhibitor | 0.094 0.017 DBMET01853 | DBMET01853 | |
| 0.055 | 0.229 | 0.205 | Cytidine deaminase inhibitor | 0.205 0.045 DBMET01853 | DBMET01853 | |
| 0.043 | 0.219 | 0.155 | Cystathionine beta-synthase inhibitor | 0.155 0.038 DBMET01853 | DBMET01853 | |
| 0.05 | 0.226 | 0.128 | Interleukin 5 antagonist | 0.128 0.019 DBMET01853 | DBMET01853 | |
| 0.023 | 0.201 | 0.105 | Lipase inhibitor | 0.105 0.025 DBMET01853 | DBMET01853 | |
| 0.032 | 0.228 | 0.081 | Glycine receptor antagonist | 0.081 0.054 DBMET01853 | DBMET01853 | |
| 0.041 | 0.238 | 0.142 | Anabolic | 0.142 0.022 DBMET01853 | DBMET01853 | |
| 0.075 | 0.271 | 0.231 | DNA repair enzyme inhibitor | 0.231 0.006 DBMET01853 | DBMET01853 | |
| 0.121 | 0.326 | 0.236 | Insulysin inhibitor | 0.236 0.11 DBMET01853 | DBMET01853 | |
| 0.128 | 0.333 | 0.235 | Tyrosine 3 hydroxylase inhibitor | 0.235 0.084 DBMET01853 | DBMET01853 | |
| 0.114 | 0.322 | 0.311 | Vasodilator, coronary | 0.311 0.079 DBMET01853 | DBMET01853 | |
| 0.03 | 0.238 | 0.062 | Interferon inducer | 0.062 0.049 DBMET01853 | DBMET01853 | |
| 0.014 | 0.225 | 0.039 | Integrin alpha2 antagonist | 0.039 0.022 DBMET01853 | DBMET01853 | |
| 0.045 | 0.258 | 0.104 | Electrolyte absorption antagonist | 0.104 0.053 DBMET01853 | DBMET01853 | |
| 0.017 | 0.231 | 0.06 | Alpha-mannosidase inhibitor | 0.06 0.027 DBMET01853 | DBMET01853 | |
| 0.033 | 0.247 | 0.057 | Ryanodine receptor antagonist | 0.057 0.047 DBMET01853 | DBMET01853 | |
| 0.102 | 0.317 | 0.303 | Gastrin inhibitor | 0.303 0.031 DBMET01853 | DBMET01853 | |
| 0.012 | 0.229 | 0.049 | Mannosidase inhibitor | 0.049 0.026 DBMET01853 | DBMET01853 | |
| 0.024 | 0.245 | 0.13 | Protein kinase (CK2) inhibitor | 0.13 0.042 DBMET01853 | DBMET01853 | |
| 0.045 | 0.268 | 0.413 | Alpha-N-acetylglucosaminidase inhibitor | 0.413 0.008 DBMET01853 | DBMET01853 | |
| 0.008 | 0.232 | 0.078 | Nicotinic acid receptor 2 agonist | 0.078 0.008 DBMET01853 | DBMET01853 | |
| 0.028 | 0.264 | 0.074 | Interferon agonist | 0.074 0.063 DBMET01853 | DBMET01853 | |
| 0.01 | 0.246 | 0.065 | Adenosine A2b receptor antagonist | 0.065 0.02 DBMET01853 | DBMET01853 | |
| 0.012 | 0.252 | 0.044 | Membrane dipeptidase inhibitor | 0.044 0.021 DBMET01853 | DBMET01853 | |
| 0.013 | 0.255 | 0.07 | NMDA receptor glycine site agonist | 0.07 0.036 DBMET01853 | DBMET01853 | |
| 0.014 | 0.261 | 0.202 | Phosphofructokinase-1 inhibitor | 0.202 0.011 DBMET01853 | DBMET01853 | |
| 0.122 | 0.37 | 0.286 | Calcium channel activator | 0.286 0.107 DBMET01853 | DBMET01853 | |
| 0.01 | 0.261 | 0.074 | Aldose reductase inhibitor | 0.074 0.025 DBMET01853 | DBMET01853 | |
| 0.055 | 0.319 | 0.149 | Anticonvulsant | 0.149 0.13 DBMET01853 | DBMET01853 | |
| 0.005 | 0.27 | 0.033 | Methionyl aminopeptidase 1 inhibitor | 0.033 0.021 DBMET01853 | DBMET01853 | |
| 0.021 | 0.288 | 0.064 | NMDA receptor agonist | 0.064 0.042 DBMET01853 | DBMET01853 | |
| 0.049 | 0.324 | 0.22 | Anesthetic general | 0.22 0.064 DBMET01853 | DBMET01853 | |
| 0.03 | 0.306 | 0.072 | Glycine receptor agonist | 0.072 0.051 DBMET01853 | DBMET01853 | |
| 0.011 | 0.287 | 0.087 | Phosphodiesterase VII inhibitor | 0.087 0.02 DBMET01853 | DBMET01853 | |
| 0.035 | 0.312 | 0.092 | Phosphodiesterase I inhibitor | 0.092 0.055 DBMET01853 | DBMET01853 | |
| 0.04 | 0.318 | 0.204 | Adenylate cyclase inhibitor | 0.204 0.025 DBMET01853 | DBMET01853 | |
| 0.078 | 0.37 | 0.214 | Superoxide dismutase inhibitor | 0.214 0.103 DBMET01853 | DBMET01853 | |
| 0.01 | 0.303 | 0.075 | Acyl-CoA dehydrogenase inhibitor | 0.075 0.024 DBMET01853 | DBMET01853 | |
| 0.006 | 0.301 | 0.056 | Phosphorylase inhibitor | 0.056 0.027 DBMET01853 | DBMET01853 | |
| 0.015 | 0.309 | 0.083 | Androgen agonist | 0.083 0.022 DBMET01853 | DBMET01853 | |
| 0.026 | 0.322 | 0.108 | Glutamate dehydrogenase inhibitor | 0.108 0.027 DBMET01853 | DBMET01853 | |
| 0.019 | 0.319 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.024 DBMET01853 | DBMET01853 | |
| 0.096 | 0.395 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.144 0.059 DBMET01853 | DBMET01853 | |
| 0.005 | 0.306 | 0.053 | AMPA receptor antagonist | 0.053 0.029 DBMET01853 | DBMET01853 | |
| 0.004 | 0.306 | 0.032 | Phosphoglycerate kinase inhibitor | 0.032 0.029 DBMET01853 | DBMET01853 | |
| 0.057 | 0.362 | 0.152 | GABA C receptor rho-2 antagonist | 0.152 0.071 DBMET01853 | DBMET01853 | |
| 0.047 | 0.352 | 0.162 | Adenylate kinase inhibitor | 0.162 0.022 DBMET01853 | DBMET01853 | |
| 0.062 | 0.368 | 0.187 | Succinate dehydrogenase inhibitor | 0.187 0.06 DBMET01853 | DBMET01853 | |
| 0.007 | 0.314 | 0.131 | Nicotinic acid receptor agonist | 0.131 0.004 DBMET01853 | DBMET01853 | |
| 0.016 | 0.325 | 0.068 | Glucose-6-phosphate isomerase inhibitor | 0.068 0.013 DBMET01853 | DBMET01853 | |
| 0.015 | 0.329 | 0.073 | Glutamate decarboxylase inhibitor | 0.073 0.051 DBMET01853 | DBMET01853 | |
| 0.025 | 0.343 | 0.089 | Aminopeptidase B inhibitor | 0.089 0.074 DBMET01853 | DBMET01853 | |
| 0.031 | 0.352 | 0.104 | GABA C receptor rho-1 antagonist | 0.104 0.057 DBMET01853 | DBMET01853 | |
| 0.032 | 0.355 | 0.129 | Xanthine oxidase inhibitor | 0.129 0.043 DBMET01853 | DBMET01853 | |
| 0.006 | 0.332 | 0.056 | Purinergic P2Y antagonist | 0.056 0.021 DBMET01853 | DBMET01853 | |
| 0.014 | 0.341 | 0.12 | Histidine decarboxylase inhibitor | 0.12 0.025 DBMET01853 | DBMET01853 | |
| 0.006 | 0.336 | 0.057 | Adenosine A2 receptor antagonist | 0.057 0.052 DBMET01853 | DBMET01853 | |
| 0.101 | 0.432 | 0.258 | Nitric-oxide synthase stimulant | 0.258 0.028 DBMET01853 | DBMET01853 | |
| 0.032 | 0.363 | 0.18 | Triose-phosphate isomerase inhibitor | 0.18 0.014 DBMET01853 | DBMET01853 | |
| 0.011 | 0.345 | 0.067 | Adenosine deaminase inhibitor | 0.067 0.015 DBMET01853 | DBMET01853 | |
| 0.006 | 0.342 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.034 DBMET01853 | DBMET01853 | |
| 0.059 | 0.395 | 0.228 | Tumour necrosis factor antagonist | 0.228 0.039 DBMET01853 | DBMET01853 | |
| 0.026 | 0.366 | 0.109 | GABA C receptor antagonist | 0.109 0.065 DBMET01853 | DBMET01853 | |
| 0.062 | 0.404 | 0.217 | Alpha-glucosidase inhibitor | 0.217 0.208 DBMET01853 | DBMET01853 | |
| 0.007 | 0.349 | 0.076 | Adenosine A1 receptor antagonist | 0.076 0.03 DBMET01853 | DBMET01853 | |
| 0.009 | 0.356 | 0.106 | Xanthine dehydrogenase inhibitor | 0.106 0.014 DBMET01853 | DBMET01853 | |
| 0.009 | 0.358 | 0.101 | Alcohol oxidase inhibitor | 0.101 0.018 DBMET01853 | DBMET01853 | |
| 0.033 | 0.384 | 0.075 | MAP kinase kinase 7 inhibitor | 0.075 0.061 DBMET01853 | DBMET01853 | |
| 0.028 | 0.38 | 0.07 | Glutamate (mGluR6) antagonist | 0.07 0.039 DBMET01853 | DBMET01853 | |
| 0.018 | 0.371 | 0.131 | Phosphodiesterase 3A inhibitor | 0.131 0.019 DBMET01853 | DBMET01853 | |
| 0.012 | 0.372 | 0.054 | AICAR transformylase inhibitor | 0.054 0.018 DBMET01853 | DBMET01853 | |
| 0.078 | 0.442 | 0.334 | Vasodilator, peripheral | 0.334 0.081 DBMET01853 | DBMET01853 | |
| 0.076 | 0.458 | 0.175 | 5 Hydroxytryptamine release stimulant | 0.175 0.146 DBMET01853 | DBMET01853 | |
| 0.05 | 0.433 | 0.147 | Adenylate cyclase stimulant | 0.147 0.068 DBMET01853 | DBMET01853 | |
| 0.022 | 0.405 | 0.09 | Creatine kinase inhibitor | 0.09 0.071 DBMET01853 | DBMET01853 | |
| 0.018 | 0.403 | 0.119 | Alkylator | 0.119 0.069 DBMET01853 | DBMET01853 | |
| 0.016 | 0.403 | 0.111 | Adrenaline agonist | 0.111 0.03 DBMET01853 | DBMET01853 | |
| 0.106 | 0.505 | 0.223 | 5 Hydroxytryptamine uptake stimulant | 0.223 0.113 DBMET01853 | DBMET01853 | |
| 0.023 | 0.424 | 0.117 | Keratolytic | 0.117 0.023 DBMET01853 | DBMET01853 | |
| 0.011 | 0.412 | 0.058 | Aconitate hydratase inhibitor | 0.058 0.028 DBMET01853 | DBMET01853 | |
| 0.005 | 0.406 | 0.092 | Carbonic anhydrase VB inhibitor | 0.092 0.018 DBMET01853 | DBMET01853 | |
| 0.007 | 0.415 | 0.092 | Dihydroorotate dehydrogenase inhibitor | 0.092 0.013 DBMET01853 | DBMET01853 | |
| 0.094 | 0.511 | 0.281 | Interleukin 2 agonist | 0.281 0.088 DBMET01853 | DBMET01853 | |
| 0.011 | 0.432 | 0.066 | Metalloproteinase-9 inhibitor | 0.066 0.064 DBMET01853 | DBMET01853 | |
| 0.041 | 0.467 | 0.203 | Interleukin agonist | 0.203 0.118 DBMET01853 | DBMET01853 | |
| 0.021 | 0.45 | 0.087 | MAP kinase kinase 1 inhibitor | 0.087 0.074 DBMET01853 | DBMET01853 | |
| 0.03 | 0.46 | 0.093 | DOPA decarboxylase inhibitor | 0.093 0.092 DBMET01853 | DBMET01853 | |
| 0.028 | 0.464 | 0.185 | Mannose-6-phosphate isomerase inhibitor | 0.185 0.039 DBMET01853 | DBMET01853 | |
| 0.033 | 0.471 | 0.093 | Phosphodiesterase 6D inhibitor | 0.093 0.067 DBMET01853 | DBMET01853 | |
| 0.017 | 0.456 | 0.057 | Purinergic P2X1 antagonist | 0.057 0.048 DBMET01853 | DBMET01853 | |
| 0.009 | 0.447 | 0.077 | Collagenase 3 inhibitor | 0.077 0.027 DBMET01853 | DBMET01853 | |
| 0.034 | 0.475 | 0.232 | Peroxidase inhibitor | 0.232 0.051 DBMET01853 | DBMET01853 | |
| 0.022 | 0.471 | 0.142 | MAP kinase kinase 2 inhibitor | 0.142 0.129 DBMET01853 | DBMET01853 | |
| 0.038 | 0.488 | 0.093 | Hematopoietic | 0.093 0.044 DBMET01853 | DBMET01853 | |
| 0.028 | 0.48 | 0.096 | Granulocyte macrophage colony stimulating factor agonist | 0.096 0.04 DBMET01853 | DBMET01853 | |
| 0.009 | 0.464 | 0.066 | Phenylalanine 4-hydroxylase inhibitor | 0.066 0.051 DBMET01853 | DBMET01853 | |
| 0.009 | 0.467 | 0.151 | Porphobilinogen synthase inhibitor | 0.151 0.02 DBMET01853 | DBMET01853 | |
| 0.091 | 0.551 | 0.28 | 5 Hydroxytryptamine release inhibitor | 0.28 0.189 DBMET01853 | DBMET01853 | |
| 0.048 | 0.508 | 0.13 | MAP kinase 3 inhibitor | 0.13 0.107 DBMET01853 | DBMET01853 | |
| 0.01 | 0.49 | 0.087 | Carbonic anhydrase VA inhibitor | 0.087 0.032 DBMET01853 | DBMET01853 | |
| 0.005 | 0.493 | 0.097 | Phosphodiesterase 3B inhibitor | 0.097 0.012 DBMET01853 | DBMET01853 | |
| 0.025 | 0.519 | 0.116 | Amylase inhibitor | 0.116 0.084 DBMET01853 | DBMET01853 | |
| 0.011 | 0.508 | 0.094 | Alcohol dehydrogenase inhibitor | 0.094 0.059 DBMET01853 | DBMET01853 | |
| 0.014 | 0.511 | 0.138 | Mucolytic | 0.138 0.04 DBMET01853 | DBMET01853 | |
| 0.008 | 0.506 | 0.084 | Carbonic anhydrase V inhibitor | 0.084 0.034 DBMET01853 | DBMET01853 | |
| 0.011 | 0.513 | 0.069 | Beta 2 adrenoreceptor agonist | 0.069 0.02 DBMET01853 | DBMET01853 | |
| 0.026 | 0.532 | 0.103 | DNA polymerase I inhibitor | 0.103 0.083 DBMET01853 | DBMET01853 | |
| 0.009 | 0.535 | 0.048 | Beta adrenoreceptor agonist | 0.048 0.021 DBMET01853 | DBMET01853 | |
| 0.078 | 0.61 | 0.319 | Caspase 9 stimulant | 0.319 0.174 DBMET01853 | DBMET01853 | |
| 0.021 | 0.556 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 DBMET01853 | DBMET01853 | |
| 0.015 | 0.561 | 0.069 | Adenosine A3 receptor antagonist | 0.069 0.06 DBMET01853 | DBMET01853 | |
| 0.009 | 0.555 | 0.104 | Expectorant | 0.104 0.064 DBMET01853 | DBMET01853 | |
| 0.002 | 0.549 | 0.03 | CXC chemokine 2 receptor antagonist | 0.03 0.014 DBMET01853 | DBMET01853 | |
| 0.019 | 0.569 | 0.144 | Protein kinase stimulant | 0.144 0.072 DBMET01853 | DBMET01853 | |
| 0.036 | 0.59 | 0.213 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.213 0.063 DBMET01853 | DBMET01853 | |
| 0.007 | 0.562 | 0.091 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.091 0.043 DBMET01853 | DBMET01853 | |
| 0.033 | 0.597 | 0.127 | Interferon gamma antagonist | 0.127 0.116 DBMET01853 | DBMET01853 | |
| 0.031 | 0.596 | 0.161 | DNA damaging | 0.161 0.157 DBMET01853 | DBMET01853 | |
| 0.013 | 0.584 | 0.103 | Myeloperoxidase inhibitor | 0.103 0.032 DBMET01853 | DBMET01853 | |
| 0.018 | 0.601 | 0.261 | Platelet antagonist | 0.261 0.068 DBMET01853 | DBMET01853 | |
| 0.088 | 0.692 | 0.654 | Calcium channel L-type activator | 0.654 0.004 DBMET01853 | DBMET01853 | |
| 0.038 | 0.643 | 0.384 | Histamine release inhibitor | 0.384 0.084 DBMET01853 | DBMET01853 | |
| 0.028 | 0.648 | 0.147 | Hexokinase inhibitor | 0.147 0.082 DBMET01853 | DBMET01853 | |
| 0.027 | 0.669 | 0.381 | Antibacterial | 0.381 0.086 DBMET01853 | DBMET01853 | |
| 0.027 | 0.684 | 0.218 | Cholesterol antagonist | 0.218 0.149 DBMET01853 | DBMET01853 | |
| 0.009 | 0.695 | 0.072 | Carbonic anhydrase XIII inhibitor | 0.072 0.057 DBMET01853 | DBMET01853 | |
| 0.019 | 0.719 | 0.102 | Photosensitizer | 0.102 0.086 DBMET01853 | DBMET01853 | |
| 0.004 | 0.766 | 0.055 | Phosphodiesterase 2A inhibitor | 0.055 0.028 DBMET01853 | DBMET01853 | |
| 0.004 | 0.775 | 0.063 | Phosphodiesterase II inhibitor | 0.063 0.029 DBMET01853 | DBMET01853 | |
| 0.017 | 0.882 | 0.154 | Hepatoprotectant | 0.154 0.106 DBMET01853 | DBMET01853 | |
| 0.004 | 0.906 | 0.142 | Bronchodilator | 0.142 0.034 DBMET01853 | DBMET01853 | |
| 0.005 | 0.912 | 0.245 | Antiobesity | 0.245 0.161 DBMET01853 | DBMET01853 | |
| 0.005 | 0.936 | 0.504 | Cyclophilin D inhibitor | 0.504 0.049 DBMET01853 | DBMET01853 | |
| 0.005 | 0.949 | 0.462 | Toll-Like receptor 7 agonist | 0.462 0.04 DBMET01853 | DBMET01853 | |
| 0.005 | 0.952 | 0.462 | Toll-Like receptor agonist | 0.462 0.04 DBMET01853 | DBMET01853 | |
| 0.004 | 0.984 | 0.239 | Hypolipemic | 0.239 0.073 DBMET01853 | DBMET01853 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |